首頁 > 市場調查報告書 > 醫療設備

導管心血管設備

市場調查報告書

商品編碼

1425074

冠狀動脈支架市場－2024年至2029年預測

Coronary Stent Market - Forecasts from 2024 to 2029

出版日期: 2024年01月22日 | 出版商:

Knowledge Sourcing Intelligence | 英文 143 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

2022年冠狀動脈支架市場估值為92.6億美元。

在冠狀動脈中放置一種可擴張的管狀金屬植入，稱為冠狀動脈支架 (CS)，由於潛在的動脈粥狀硬化而使用。這種重組手術稱為經皮冠狀動脈介入治療 (PCI) 或冠狀動脈支架置放術。此外，冠狀動脈支架的可擴張金屬網膜可減少有害的重塑、冠狀動脈夾層和血管反沖。

冠狀動脈支架市場的促進因素

推動冠狀動脈支架需求的主要因素是心臟病盛行率的增加。隨著糖尿病、高血壓和肥胖等疾病的盛行率不斷增加，冠狀動脈心臟病在全球變得越來越常見。隨著人口老化，預計需要更多的冠狀動脈支架。由於該領域技術的發展，冠狀動脈支架市場正在不斷成長。這些新設備改善的患者治療效果、安全性和有效性推動了冠狀動脈支架市場的成長。

冠狀動脈疾病盛行率上升

根據美國國家醫學圖書館 2021 年 6 月發表的一項研究，冠狀動脈疾病是美國的首要死因，每年造成約 61 萬人死亡。因此，由於 CAD 發生率空前上升，對有效冠狀動脈支架技術的需求預計將會成長。預計此因素將在預測期內維持需求。由於冠狀動脈支架用於大多數經皮冠狀動脈介入治療（PCI）手術，因此冠狀動脈支架市場預計將擴大。

擴展 DES 的日益普及

與傳統的球囊血管成形術相比，增強型 DES 和生物可吸收支架的發展提高了支架留置技術的普及度。冠狀動脈支架的技術進步，例如雙支架的發明和生物分解性材料的使用，提高了CVD治療的有效性和結果。上述因素可能會在整個預測期內推動冠狀動脈支架市場的成長。

加大醫療保健投資

美國衛生與公眾服務部醫療保險與醫療補助服務中心預測，2021 年美國醫療保健支出將成長 2.7%，達到 4.3 兆美元。隨著醫療費用的增加，更多的患者將能夠接受支架置入治療，從而刺激冠狀動脈支架市場的成長。此外，政府和私人公司的優惠報銷政策正在為更多人提供支架置入治療，這推動了需求。

BMS支架越來越受歡迎

由於新技術的進入障礙較低，且臨床證據證明了 BMS 的優越性，BMS 支架持續成長。 BMS 支架類型因其實惠的設備價格而能夠保持其在冠狀動脈支架市場的地位。由於其低成本和低住院率，BMS 被用於許多 PCI 手術中，儘管 DES 的改進已經取代了它的使用。繼DES之後，生物可吸收支架（BRS）是市場上出現的最新技術。

技術進步

由於多項技術進步使冠狀動脈支架行業具有吸引力，預計冠狀動脈支架的需求將在預測期內顯著增加。持續的研究和開發導致了第一個完全可溶解支架的開發。這些支架剛剛獲得 FDA 批准進入冠狀動脈支架市場，用於大多數心血管手術。隨著冠狀動脈疾病的增加，對這些治療的需求可能會增加。

北美冠狀動脈支架市場預計將逐步擴大。

冠狀動脈支架技術的技術進步，如藥物釋放型支架和生物分解性材料的使用，正在進一步加速冠狀動脈支架市場的擴張。在冠狀動脈支架產業中，亞太地區預計收益將成長最快。冠狀動脈支架市場也受到 CAD篩檢加強、經濟成長、監管更新以及一些國家高度優惠的報銷等原因的推動。此外，該產業也受到政府對醫療保健投資增加以及印度和中國等成本受限地區降低產品價格的新措施的影響。

主要市場參與者的策略

在全球冠狀動脈支架市場中，雅培（Abbott）實驗室、波士頓科學（Boston Scientific）和美敦力（Medtronic）憑藉在利潤豐厚的 DES 市場上的良好記錄以及包括各種不同類型 IC 設備的廣泛產品系列而擁有強大的影響力。這些公司在業界佔有重要地位。儘管三大廠商佔據主導地位，但國內外已有多家企業進入冠脈支架產業。例如，百多力透過提供實惠的價格和填補冠狀動脈支架市場空白的最尖端科技，建立了強大的影響力。

The placement of expandable tubular metallic implants called coronary stents (CS) into coronary arteries that have been used due to the underlying atherosclerotic disease. This revascularization procedure is known as percutaneous coronary intervention (PCI) or coronary angioplasty with stent placement. Additionally, due to the expandable, metallic meshwork of coronary stents, which inhibits adverse remodeling, coronary dissection, and vascular recoil have been removed.

Driving factors for the coronary stents market

The growing incidence of heart disease is the primary factor driving the need for coronary stents. With the increasing prevalence of diseases including diabetes, hypertension, and obesity, CAD is becoming more common globally. As the population ages, more coronary stents are expected to be required. The coronary stent market is growing as a result of technological developments in the field. The improved patient outcomes, safety, and efficacy of these novel devices are what is driving the coronary stent market growth.

Rising prevalence of coronary artery disease

In the US, coronary artery disease, is the leading cause of death, accounting for about 610,000 fatalities yearly according to research published in the National Library of Medicine in June 2021. The need for effective coronary stent technology is thus expected to expand as a result of the unprecedented rise in CAD incidence. This factor is expected to sustain demand during the forecast timeframe. Since most Percutaneous Coronary Intervention (PCI) operations involve the use of a coronary stent, the coronary stent market is expected to grow.

Growing popularity for enhanced DES

Enhanced DES and the creation of bioresorbable scaffolds have increased the popularity of stenting technology relative to conventional balloon angioplasty. The efficacy and outcomes of treating CVD have improved due to technical advancements in coronary stents, such as the invention of bifurcation stents and the use of biodegradable materials. The aforementioned elements are likely to drive coronary stent market growth throughout the forecast period.

Increasing investment in healthcare

The Centres for Medicare & Medicaid Services of the United States Department of Health and Human Services estimate that U.S. healthcare spending will increase 2.7 percent in 2021 to reach $4.3 trillion. More patients can obtain stent installation treatments as healthcare spending rises, fueling coronary stent market growth. Additionally, more people have access to stent installation treatments because of favorable reimbursement policies from governments and private insurance companies, which is fueling demand.

Rising popularity for BMS stents

BMS stents continue to grow due to low entry hurdles for new technologies and clinical evidence showing BMS's advantages. The BMS stent type can keep its position in the coronary stent market because of its affordable device price. BMS is utilized in many PCI procedures despite the improvement in DES replacing its use because of its inexpensive cost and low hospitalization rates. After DES, bioresorbable scaffolds (BRS) are the most recent technology to hit the market.

Advancement in technology

Demand for coronal stents is expected to rise considerably throughout the projection period due to several technical advancements that have made the coronary stent industry appealing. Continuous research and development led to the first completely dissolving stents. These stents, which were just introduced to the coronary stent market after receiving FDA permission, are utilized in the majority of cardiac operations. There will be a higher need for these therapies as incidences of coronary artery disease rise.

The market for coronary stents is expected to expand gradually in North America.

Technical advancements in coronary stent technologies, such as drug-eluting stents and the use of biodegradable materials, have further sped up the expansion of the coronary stent market. Asia Pacific is expected to see the fastest revenue growth in the coronary stent industry. The market for coronary stents is also driven by other reasons including enhanced CAD screening, economic growth, regulatory updates, and very favorable reimbursement in some countries. Additionally, this industry is being impacted by growing government investment in healthcare and new attempts to provide products at cheap costs in cost-constrained regions like India and China.

Key market player strategies

In the global coronary stent market, Abbott Laboratories, Boston Scientific, and Medtronic had a large presence due to their outstanding performance in the lucrative DES market and their extensive product portfolios, which include a wide range of various IC device types. These businesses have established a noticeable presence in the industry. Despite the three main manufacturers' dominance, there are several national and international participants in the coronary stent industry. By providing affordable prices and cutting-edge technologies that fill gaps in the coronary stent market, BIOTRONIK, for instance, has been able to build a sizable presence.

Market Key Developments

In April 2023, leading medical device firm Terumo Europe N.V. started a new prospective clinical research using the Ultimaster NagomiTM sirolimus-eluting coronary stent system in patients undergoing difficult PCI to further product and patient care innovation.
In August 2022, Medtronic introduced the Onyx Frontier drug-eluting stent in Europe.
In July 2022, the unique Pulsar®-18 T3 peripheral self-expanding stent system from BIOTRONIK was approved by the U.S. Food and Drug Administration (FDA) for a better insertion method during endovascular treatments, the company stated.

Segmentation:

By Type

Bare-metal Stents
Drug-eluting Stents
Bioabsorbable Stents

By Delivery Mode

Balloon-expandable Stents
Self-expanding Stents

By End-User

Hospitals
Cardiac Centers
Ambulatory Surgical Centers

By Geography

North America
United States
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
Japan
China
India
South Korea
Indonesia
Thailand
Others

1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Data
2.2. Assumptions

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Force Analysis
- 4.3.1. Bargaining Power of Suppliers
- 4.3.2. Bargaining Power of Buyers
- 4.3.3. Threat of New Entrants
- 4.3.4. Threat of Substitutes
- 4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. CORONARY STENT MARKET, BY TYPE

5.1. Introduction
5.2. Bare-metal Stents
5.3. Drug-eluting Stents
5.4. Bioabsorbable Stents

6. CORONARY STENT MARKET, BY DELIVERY MODE

6.1. Introduction
6.2. Balloon-expandable Stents
6.3. Self-expanding Stents

7. CORONARY STENT MARKET, BY END-USER

7.1. Introduction
7.2. Hospitals
7.3. Cardiac Centers
7.4. Ambulatory Surgical Centers

8. CORONARY STENT MARKET, BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. United States
- 8.2.2. Canada
- 8.2.3. Mexico
8.3. South America
- 8.3.1. Brazil
- 8.3.2. Argentina
- 8.3.3. Others
8.4. Europe
- 8.4.1. United Kingdom
- 8.4.2. Germany
- 8.4.3. France
- 8.4.4. Spain
- 8.4.5. Others
8.5. The Middle East and Africa
- 8.5.1. Saudi Arabia
- 8.5.2. UAE
- 8.5.3. Israel
- 8.5.4. Others
8.6. Asia Pacific
- 8.6.1. Japan
- 8.6.2. China
- 8.6.3. India
- 8.6.4. South Korea
- 8.6.5. Indonesia
- 8.6.6. Thailand
- 8.6.7. Others